Global consortium looks to RNA-based anti-cancer immunotherapy

CanceRNA has been set up, a global consortium aiming to apply RNA-based therapeutics to successfully unlock anti-cancer immune responses. 

Related Keywords

Jerusalem ,Israel General ,Israel ,Lisbon ,Lisboa ,Portugal ,Brussels ,Bruxelles Capitale ,Belgium ,Spain ,Hebrew University ,Yerushalayim ,Amsterdam ,Noord Holland ,Netherlands ,Barcelona ,Comunidad Autonoma De Cataluna ,Tanja Degruijl ,Daniel Helman ,Michal Lotem ,Rotem Karni ,Juan Valcarcel ,Maria Carmo Fonseca ,Regine Shevach ,Seth Salpeter ,Lynne Maquat ,Evelien Smits ,Erez Levanon ,Pablo Menendez ,Simon Geissler ,Hadassah Medical School ,University Of Lisbon ,University Of Amsterdam ,Jose Carreras Leukemia Institute ,Niels Schaft Of The University Erlangen ,Bar Ilan University ,University Of Brussels ,University Of Rochester ,Hadassah University Medical Center ,Hadassah Cancer Research Institute ,Department Chair ,Molecular Biology ,Hebrew University Hadassah Medical School ,Genomic Regulation ,Niels Schaft ,